Enjoy complimentary customisation on priority with our Enterprise License!
The global breast tissue expander market size is estimated to grow by USD 267.59 million at a CAGR of 6.82% between 2022 and 2027. Companies are increasing R&D investment to help develop safe and efficient breast tissue expanders for the treatment of breast cancer. With the increasing prevalence of breast cancer, they are developing shells with a smooth texture for breast expanders to increase patient compliance. For instance, in May 2020, POLYTECH Health and Aesthetics GmbH announced notable investment and operational expansion by shifting its headquarters to a state-of-the-art facility near Dieburg, Germany. This will happen within the next few years and shall improve production and overall efficiency. Moreover, Establishment Labs started work on its third facility in 2021 for the expansion of operations that include manufacturing, R&D, and medical education. It seeks to further expand its market by tapping into countries with growth potential like China and the US. Hence such factors will positively impact the breast tissue expander market. This market research and growth report also includes an in-depth analysis of drivers, trends, and challenges.
To learn more about this report, Request Free Sample
Technavio has segmented the market into End-user, Product, and Geography. The market is significantly influenced by the market, driven by the increasing prevalence of breast cancer and rising awareness for the reconstruction treatment. Reimbursements play a crucial role in market growth, with large hospitals, specialty and multispecialty facilities, procuring these in bulk. These hospitals engage closely with suppliers, reimbursement authorities, and government organizations. Small hospitals, however, face budget constraints and often avoid purchasing these devices due to the high costs associated with breast augmentation and reconstruction.
Advancements in medical technology include the use of 3D-printed implants, Resomer bioresorbable polymer, and silicone implants in breast reconstruction. Clinical trials are ongoing for tissue expanders, liposuction, and other surgical techniques to improve outcomes and reduce complications such as capsular contracture and product failures. Recalls and product failures, particularly from major players like Allergan, have impacted the breast implants segment. These surgeries and cosmetic procedures continue to drive market growth, with shape insights including round, crescent, and rectangular implants. Regulatory challenges and aging population contribute to market trends. Ambulatory Surgical Centres and clinics also offer breast augmentation services using various surgical techniques. Forehead, scalp, face & neck reconstruction are other applications for breast tissue expanders. Cosmetology clinics and Aesthetic surgeries are also significant end-users.
Hospitals
The market share growth by the hospitals segment will be significant during the forecast period. Large- and medium-sized hospitals are purchasing advanced breast tissue expander devices to provide extensive mastectomy and breast reconstruction services. Specialty hospitals procure advanced medical infrastructure in bulk from specific suppliers and engage with reimbursement authorities and government organizations.
Get a glance at the market contribution of various segments View a PDF Sample
The hospitals segment was valued at USD 290.63 million in 2017. Hospitals and healthcare centers like the Johns Hopkins Hospital in the US and Fortis Healthcare in India are spreading awareness among patients and healthcare professionals about breast reconstruction. This is benefiting the growth of the market. Moreover, there is increasing demand for these procedures for aesthetic purposes, mastectomy, and other surgeries. All these factors will boost the market growth of this segment during the forecast period.
Saline-filled breast tissue expanders
The saline-filled breast tissue expanders segment includes expanders that are filled with normal saline for about 6-8 weeks for the expansion. They are used for breast reconstruction surgeries, breast augmentation, and for breast deformity correction. They are surgically placed between the skin and chest muscle tissue, and then regular saline injections are used to obtain equal-sized breasts. Moreover, companies offer different types such as round, anatomical, and crescent saline-filled breast tissue expanders. Hence, the ease of access and the wide availability of saline-filled expanders will help boost the growth of this segment of the market during the forecast period.
The air-filled breast tissue expanders segment includes expanders that use carbon dioxide for tissue expansion. In two-stage breast reconstruction after mastectomy, soft tissue expansion can be conducted using this type of expander. They are composed of a sterile implant with an outer silicone shell that serves as a carbon dioxide reservoir and a remote dosage controller to release carbon dioxide and inflate the expander. Expansion of product portfolios by companies to expand their market share, and the elimination of frequent hospital visits, and minimally invasive procedure help increase patient compliance. Hence such factors will boost the market growth of this segment of the market during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period.
The market in North America has experienced significant growth due to the increasing number of cases, particularly among women under the age of 45. According to the Centers for Disease Control and Prevention (CDC), approximately 247,000 breast cancer cases are diagnosed annually in the US. Risk factors for breast cancer include aging, genetic mutations, reproductive history, family history, and non-cancerous breast diseases. The treatment options include surgical oncology, breast conserving surgery, and reconstruction.
Patient satisfaction and quality of life are crucial considerations in these procedures. Post-surgery complications and scar management are significant concerns for patients undergoing breast tissue expansion or reconstruction. Patient preferences play a vital role in the choice of treatment and reconstruction options. Therefore, advancements in surgical techniques and technologies to minimize complications and improve scar management are essential in the market
Buy Now Full Report and Discover More
The market is a significant segment within the larger arena of aesthetic and reconstructive surgeries. This market caters to the demand for these following breast cancer surgeries like mastectomy. Reimbursements for such procedures are crucial, making regulatory approvals and clinical trials essential. 3D-printed implants using Resomer bioresorbable polymer are emerging trends in this market. Silicone implants continue to dominate due to their proven track record, but product failures and recalls have led to increased scrutiny. Companies like Allergan offer a range of solutions, including tissue expanders and acellular dermal matrices. The aging population's increasing need for aesthetic surgeries and the high costs have led to the growth of ambulatory surgical centres and hospitals as alternatives to clinics. Reconstructive surgeries for forehead skin reconstruction, scalp reconstruction, and face & neck reconstruction also impact the market dynamics. Regulatory challenges remain a significant hurdle, impacting market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
The growing business strategies and FDA approval is driving the market growth. The breast reconstruction market caters to women undergoing the cancer treatment, which includes mastectomy procedures. Post-mastectomy, breast reconstruction surgeries employ breast expanders. Rising cancer cases, primarily due to aging and genetic factors, fuel market growth. In the US, approximately 245,000 women are diagnosed yearly. Reimbursements and awareness drive the demand for breast reconstruction treatments. Silicone implants and 3D-printed implants are common choices, with tissue expanders and acellular dermal matrix also in use. Clinical trials and surgical techniques, including liposuction and capsular contracture prevention, are under investigation. Product recalls and failures, such as those involving Allergan breast implants, pose challenges. Regulatory hurdles, high costs, and the aging population's increasing need for aesthetic surgeries further impact the market. Market segments include breast implants and tissue expanders. Product shape insights encompass rectangular, crescent, and round implants, with applications in forehead skin, scalp, face & neck reconstruction, and breast augmentation procedures.
The growing awareness programs for breast cancer are a key trend in the market. The market expands in response to the rising prevalence of this type of cancer and related risk factors, including genetic mutations, reproductive history, radiation therapy, alcohol consumption, and hormone intake. To combat this disease, various organizations and vendors in the global market promote awareness and education programs, as well as breast screening facilities for early detection. In developed countries like Australia, government initiatives such as the BreastScreen Australia program provide cancer screening for the population. The market comprises tissue expanders, silicone implants, 3D-printed implants, and other products. Clinical trials and surgical techniques, including liposuction and capsular contracture prevention, are underway to address product failures and recalls. Key players in the market include Allergan, known for its breast implants segment. The market encompasses reconstructive surgeries, cosmetic procedures, and medical technology advancements, including the use of the Acellular Dermal Matrix and Resomer bioresorbable polymer. Regulatory challenges and high costs are significant market barriers. Ambulatory Surgical Centres, Hospitals, and Clinics offer various breast such treatments, including breast augmentation, mastectomy, and breast prosthetics.
The high costs associated with breast reconstruction surgeries are challenging market growth. The global market is influenced by the market, particularly in the context of cancer treatment. High costs, including follow-up fees, diagnostic tests, hospital stays, and breast implant expenses, can hinder market growth, especially in developing countries like South Africa, where the average cost of reconstructive surgery ranges from USD 3100 to USD 10,000, and the cost of mastectomy is approximately USD 4,500. These extensive costs can impact patient compliance and limit access to breast reconstruction treatment. Breast prosthetics, such as silicone implants and 3D-printed implants using Resomer bioresorbable polymer, are essential components of the market.
Clinical trials and surgical techniques, including liposuction and tissue expanders using an acellular dermal matrix, contribute to the advancement of breast reconstruction technology. However, challenges such as product failures, recalls, and regulatory issues persist, affecting market growth. Breast reconstruction surgeries encompass both reconstructive procedures and cosmetic surgeries. These surgeries include mastectomy, while cosmetic procedures include breast augmentation using various shapes like round, crescent, and rectangular implants. The aging population and increasing awareness of aesthetic surgeries contribute to the market's growth. Despite these opportunities, challenges remain, including high costs, regulatory hurdles, and competition from ambulatory surgical centres, hospitals, and clinics. Key players in the market include Allergan, known for its breast implant segment, and companies focusing on tissue expanders and other reconstruction technologies. Product shape insights from cosmetology clinics and surgical techniques continue to evolve.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 11 market companies, including:
AbbVie Inc. - The company offers breast-tissue expanders such as NATRELLE 133S smooth tissue expanders.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is a significant sector in the healthcare industry, focusing on the production and distribution of devices used in breast reconstruction surgery. These expanders are designed to gradually expand the breast tissue, preparing it for breast implant surgery. The market is driven by the increasing number of these surgeries performed worldwide. The use of advanced technologies in the production of these devices, such as silicone and saline materials, contributes to their growing popularity. Additionally, the rising awareness of breast cancer and the availability of insurance coverage for related procedures are further boosting market growth. The market is expected to continue its expansion due to the increasing demand for these surgeries and the ongoing advancements in medical technology.
The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Market Scope |
|
Report Coverage |
Details |
Page number |
154 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.82% |
Market growth 2023-2027 |
USD 267.59 million |
Market structure |
Concentrated |
YoY growth 2022-2023(%) |
6.23 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 40% |
Key countries |
US, Canada, UK, Germany, and Japan |
Competitive landscape |
Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
AbbVie Inc., Establishment Labs Holdings Inc., Global Consolidated Aesthetics Ltd., Groupe SEBBIN SAS, Guangzhou Wanhe Plastic Materials Co. Ltd., Johnson and Johnson Services Inc., PMT Corp., POLYTECH Health and Aesthetics GmbH, Sientra Inc., Silimed Industria de Implantes Ltd., and Specialty Surgical Products Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.